↓ Skip to main content

French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia

Overview of attention for article published in Experimental Hematology & Oncology, December 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
Published in
Experimental Hematology & Oncology, December 2012
DOI 10.1186/2162-3619-1-39
Pubmed ID
Authors

Pascale Trioche, Brigitte Nelken, Gérard Michel, Isabelle Pellier, Arnaud Petit, Yves Bertrand, Pierre Rohrlich, Claudine Schmitt, Nicolas Sirvent, Patrick Boutard, Geneviève Margueritte, Brigitte Pautard, Stéphane Ducassou, Dominique Plantaz, Alain Robert, Caroline Thomas, Kristell Desseaux, Sylvie Chevret, André Baruchel

Abstract

Clofarabine alone or in combination with cyclophosphamide and etoposide has shown a good efficacy and a tolerable toxicity profile in previous studies of children with relapsed or refractory leukaemia. This report describes a retrospective study of 38 French patients who received clofarabine as a monotherapy or in combination for relapsed or refractory acute lymphoblastic leukaemia (ALL) outside of clinical trials after marketing authorization.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 27%
Other 3 20%
Student > Bachelor 2 13%
Student > Master 2 13%
Student > Ph. D. Student 1 7%
Other 2 13%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 8 53%
Nursing and Health Professions 1 7%
Economics, Econometrics and Finance 1 7%
Agricultural and Biological Sciences 1 7%
Sports and Recreations 1 7%
Other 1 7%
Unknown 2 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2012.
All research outputs
#2,015,983
of 3,619,417 outputs
Outputs from Experimental Hematology & Oncology
#12
of 20 outputs
Outputs of similar age
#148,519
of 277,013 outputs
Outputs of similar age from Experimental Hematology & Oncology
#1
of 2 outputs
Altmetric has tracked 3,619,417 research outputs across all sources so far. This one is in the 25th percentile – i.e., 25% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20 research outputs from this source. They receive a mean Attention Score of 2.4. This one scored the same or higher as 8 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,013 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them